Journal Article

Time to diagnosis and treatment of pulmonary tuberculosis in indigenous peoples: a systematic review

Long, Richard, Varughese, Marie, Heffernan, Courtney, Li, Michael Y.

2023

Overview

Background Time to diagnosis and treatment is a major factor in determining the likelihood of tuberculosis (TB) transmission and is an important area of intervention to reduce the reservoir of TB infection and prevent disease and mortality. Although Indigenous peoples experience an elevated incidence of TB, prior systematic reviews have not focused on this group. We summarize and report findings related to time to diagnosis and treatment of pulmonary TB (PTB) among Indigenous peoples, globally. Methods A Systematic review was performed using Ovid and PubMed databases. Articles or abstracts estimating time to diagnosis, or treatment of PTB among Indigenous peoples were included with no restriction on sample size with publication dates restricted up to 2019. Studies that focused on outbreaks, solely extrapulmonary TB alone in non-Indigenous populations were excluded. Literature was assessed using the Hawker checklist. Registration Protocol (PROSPERO): CRD42018102463. Results Twenty-four studies were selected after initial assessment of 2021 records. These included Indigenous groups from five of six geographical regions outlined by the World Health Organization (all except the European Region). The range of time to treatment (24–240 days), and patient delay (20 days–2.5 years) were highly variable across studies and, in at least 60% of the studies, longer in Indigenous compared to non-Indigenous peoples. Risk factors associated with longer patient delays included poor awareness of TB, type of health provider first seen, and self-treatment. Conclusion Time to diagnosis and treatment estimates for Indigenous peoples are generally within previously reported ranges from other systematic reviews focusing on the general population. However among literature examined in this systematic review that stratified by Indigenous and non-Indigenous peoples, patient delay and time to treatment were longer compared to non-Indigenous populations in over half of the studies. Studies included were sparse and highlight an overall gap in literature important to interrupting transmission and preventing new TB cases among Indigenous peoples. Although, risk factors unique to Indigenous populations were not identified, further investigation is needed as social determinants of health among studies conducted in medium and high incidence countries may be shared across both population groups. Trial registration N/a.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Care and treatment / Checklist / Coronaviruses / COVID-19 / Development and progression / Diagnosis / Diagnosis delay / Disease transmission / Dosage and administration / Estimates / Health aspects / Humans / Indigenous / Indigenous Peoples / Infections / Infectious Diseases / Internal Medicine / Latent Tuberculosis / Literature reviews / Medical diagnosis / Medical Microbiology / Medicine / Medicine & Public Health / Mortality / Native peoples / Pandemics / Parasitology / Patient and health system delay / Population / Populations / Prevention / Pulmonary tuberculosis / Respiratory agents / Risk Factors / Social aspects / Social determinants of health / Systematic review / Terminology / Time to diagnosis / Time to treatment / Tropical Medicine / Tuberculosis / Tuberculosis transmission / Tuberculosis, Pulmonary - diagnosis / Tuberculosis, Pulmonary - drug therapy / Tuberculosis, Pulmonary - epidemiology